NCT06095947View on ClinicalTrials.gov

Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years

CompletedOBSERVATIONAL

Enrollment

652

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

February 6, 2023

Study Completion Date

February 28, 2023

Conditions

GCP

Interventions

BIOLOGICAL

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

A total of 652326 healthy children with immunization history and no immunization history aged 3-8 years who met the program requirements received two doses of normally commercially available quadrivalent influenza vaccine according to the 0,30-day procedure.

Trial Locations (1)

250000

Kou Zengqiang, Jinan

All Listed Sponsors

lead

Hualan Biological Bacterin Co. Ltd.

INDUSTRY

NCT06095947 - Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years | Biotech Hunter | Biotech Hunter